Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of July 28, 2026, RLYB trades at $16.00 with a market cap of $86.56M and a P/E ratio of -10.26. RLYB moved -1.90% today. Year to date, RLYB is +197.15%; over the trailing twelve months it is +308.81%. Its 52-week range spans $1.76 to $17.57. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for RLYB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $16.00 |
| Market Cap | $86.56M |
| P/E Ratio | -10.26 |
| EPS | $-1.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.57 |
| 52-Week Low | $1.76 |
| Volume | 15.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $858.00K |
| Net Income | $-8.98M |
| Gross Margin | 0.00% |
RLYB analyst coverage data. Average price target: $0.00.